Anhui Huangshan Capsule Co., Ltd. (SHE:002817)
8.28
+0.03 (0.36%)
Feb 4, 2026, 3:04 PM CST
Anhui Huangshan Capsule Revenue
Anhui Huangshan Capsule had revenue of 100.20M CNY in the quarter ending September 30, 2025, a decrease of -9.90%. This brings the company's revenue in the last twelve months to 471.08M, up 3.82% year-over-year. In the year 2024, Anhui Huangshan Capsule had annual revenue of 473.48M with 2.31% growth.
Revenue (ttm)
471.08M
Revenue Growth
+3.82%
P/S Ratio
5.24
Revenue / Employee
691.75K
Employees
681
Market Cap
2.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 473.48M | 10.71M | 2.31% |
| Jan 1, 2024 | 462.77M | 34.45M | 8.04% |
| Jan 1, 2023 | 428.32M | 48.43M | 12.75% |
| Dec 31, 2021 | 379.89M | 60.46M | 18.93% |
| Dec 31, 2020 | 319.43M | -6.13M | -1.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Guhan Pharmaceutical Group | 351.79M |